Latest Molecular Therapy Stories
SAN MARINO, Calif., Sept. 7 /PRNewswire/ -- Epeius Biotechnologies Corporation, a leader in the emerging field of targeted genetic medicine, reports the publication of a landmark paper in clinical oncology. Following up on its advanced U.S.
In one of only two studies of its kind, a study from researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts demonstrates that non-viral gene therapy can delay the onset of some forms of eye disease and preserve vision.
DURHAM, N.C., Aug.
Stem cell researchers exploring a new approach for the care of respiratory diseases report that an experimental treatment involving transplantable lung cells was associated with improved outcomes in tests on mice with acute lung injury.
Drug has broad implications for a wide range of genetic diseases.
New publication in Molecular Therapy outlines dramatic effects in animals treated with splice switching PPMO, demonstrates promise for treatment of Duchenne muscular dystrophy.
Dicerna Pharmaceuticals, Inc.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.